CD36 and eye disorder: Clinical studies in patients with liver cirrhosis have also confirmed that CD36 glycosylation may promote hepatic uptake of LCFA, which may be part of the pathogenesis of liver inflammation and liver cancer [51], and this may provide a new idea for the treatment of eye diseases associated with long-chain fatty acids by dietary regulation.